Journal profile · ONCOLOGY
Chinese Clinical Oncology
ISSN 2304-3865 · eISSN 2304-3873 · AME Publishing Company
Chinese Clinical Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 1,650; median 99 days to acceptance (100 articles, last 24 months); 78 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Chinese Clinical Oncology is published by AME Publishing Company and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes and Cancer, Hypoxia, and Metabolism, together about 22% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Treatments and MutationsMedicine9.8%
- Gastric Cancer Management and OutcomesMedicine6.8%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology5.4%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine5.4%
- Lung Cancer Diagnosis and TreatmentMedicine5.2%
- Lung Cancer Research StudiesMedicine5%
- Colorectal Cancer Treatments and StudiesMedicine4.9%
- Cancer Mechanisms and TherapyMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.64LetPub ·
- SNIP 2026-06
- 0.93LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 292OpenAlex ·
- 2-year mean citedness
- 1.42OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 51LetPub ·
Articles by year OpenAlex count · 3,075 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 64 | 64 | 19 |
| 2025 | 78 | 78 | 85 |
| 2024 | 181 | 181 | 354 |
| 2023 | 76 | 76 | 523 |
| 2022 | 48 | 48 | 388 |
| 2021 | 43 | 43 | 325 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
99 daysMedian, submission to acceptance · P25–P75 74 days – 130 days
- Acceptance to online
- median 62 days (19 articles)
- Submission to online
- median 150 days
- Sample
- 100 articles with submission and acceptance dates (154 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,650 | Yes | CC BY-NC-ND |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- AME Publishing Company
- ISSN
- 2304-3865
- Electronic ISSN
- 2304-3873
- Official links
FAQ
Frequently asked questions about Chinese Clinical Oncology
What CAS zone is Chinese Clinical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Chinese Clinical Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Chinese Clinical Oncology?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 99 days (interquartile range 74–130 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Chinese Clinical Oncology?
According to LetPub and DOAJ records, Chinese Clinical Oncology is indexed in ESCI, Scopus and DOAJ.
Is Chinese Clinical Oncology open access, and what is the APC?
Chinese Clinical Oncology is a fully open-access journal. APC about USD 1,650.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .